CARBOPROST TROMETHAMINE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for carboprost tromethamine and what is the scope of freedom to operate?
Carboprost tromethamine
is the generic ingredient in two branded drugs marketed by Alembic, Amneal, Ani Pharms, Caplin, Dr Reddys, Eugia Pharma, Gland Pharma Ltd, Long Grove Pharms, Micro Labs, Sola Pharms, Steriscience Speclts, Sunny, and Pfizer, and is included in thirteen NDAs. Additional information is available in the individual branded drug profile pages.There is one drug master file entry for carboprost tromethamine. Eighteen suppliers are listed for this compound.
Summary for CARBOPROST TROMETHAMINE
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 13 |
NDAs: | 13 |
Drug Master File Entries: | 1 |
Finished Product Suppliers / Packagers: | 18 |
Raw Ingredient (Bulk) Api Vendors: | 40 |
Clinical Trials: | 3 |
Patent Applications: | 369 |
What excipients (inactive ingredients) are in CARBOPROST TROMETHAMINE? | CARBOPROST TROMETHAMINE excipients list |
DailyMed Link: | CARBOPROST TROMETHAMINE at DailyMed |
Recent Clinical Trials for CARBOPROST TROMETHAMINE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Northwestern University | Early Phase 1 |
C.R.Darnall Army Medical Center | N/A |
American University of Beirut Medical Center | N/A |
Pharmacology for CARBOPROST TROMETHAMINE
Drug Class | Prostaglandin Analog |
Medical Subject Heading (MeSH) Categories for CARBOPROST TROMETHAMINE
Anatomical Therapeutic Chemical (ATC) Classes for CARBOPROST TROMETHAMINE
US Patents and Regulatory Information for CARBOPROST TROMETHAMINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Caplin | CARBOPROST TROMETHAMINE | carboprost tromethamine | INJECTABLE;INJECTION | 216882-001 | Feb 13, 2023 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
Pfizer | HEMABATE | carboprost tromethamine | INJECTABLE;INJECTION | 017989-001 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
Dr Reddys | CARBOPROST TROMETHAMINE | carboprost tromethamine | INJECTABLE;INJECTION | 211941-001 | Jul 2, 2019 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
Alembic | CARBOPROST TROMETHAMINE | carboprost tromethamine | INJECTABLE;INJECTION | 217198-001 | Jun 15, 2023 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
Gland Pharma Ltd | CARBOPROST TROMETHAMINE | carboprost tromethamine | INJECTABLE;INJECTION | 217657-001 | Aug 7, 2023 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for CARBOPROST TROMETHAMINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pfizer | HEMABATE | carboprost tromethamine | INJECTABLE;INJECTION | 017989-001 | Approved Prior to Jan 1, 1982 | ⤷ Subscribe | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
CARBOPROST TROMETHAMINE Market Analysis and Financial Projection Experimental
More… ↓
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.